Stay updated with breaking news from Tree capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report published on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. AGLE has been the topic of several other research reports. Jonestrading restated a hold rating on shares of Aeglea BioTherapeutics in a research report on […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) dropped 10.2% during mid-day trading on Thursday . The company traded as low as $16.43 and last traded at $16.64. Approximately 490,412 shares changed hands during mid-day trading, a decline of 24% from the average daily volume of 645,541 shares. The stock had previously closed at $18.52. Analyst […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating)’s share price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously closed at $20.21, but opened at $18.84. Rhythm Pharmaceuticals shares last traded at $18.44, with a volume of 425,597 shares trading hands. The company reported ($0.92) earnings per […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) was up 4.8% on Monday . The company traded as high as $44.90 and last traded at $44.90. Approximately 94,858 shares were traded during trading, a decline of 89% from the average daily volume of 847,566 shares. The stock had previously closed at $42.83. Wall Street Analyst Weigh In […]
Shares of CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1 […]
Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Rating) were down 3.7% on Tuesday . The stock traded as low as $235.73 and last traded at $236.36. Approximately 130,338 shares were traded during trading, a decline of 68% from the average daily volume of 401,477 shares. The stock had previously closed at $245.33. Wall Street […]
Aadi Bioscience, Inc. (NASDAQ:AADI – Get Rating) Chairman Neil Desai sold 7,336 shares of the stock in a transaction dated Wednesday, April 5th. The shares were sold at an average price of $7.24, for a total transaction of $53,112.64. Following the completion of the transaction, the chairman now directly owns 1,885,755 shares in the company, […]
/PRNewswire/ -- Integreon, a trusted global provider of legal and business outsourced services, announced today that Mark R. Williams, CEO of Magna Legal...
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.